Second Hypertension Drug Recalled Due to Contamination

Share this content:
Second Hypertension Drug Recalled Due to Contamination
Second Hypertension Drug Recalled Due to Contamination

THURSDAY, Nov. 1, 2018 (HealthDay News) -- Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says.

Certain lots of irbesartan are being recalled by SciGen because they contain an industrial chemical that is a suspected carcinogen, CNN reported. The recalled drugs have "Westminster Pharmaceuticals" and "GSMS Inc." on the label.

Another heart drug, valsartan, was recalled recently due to contamination with possible cancer-causing chemicals, CNN reported.

Not all medicines that contain valsartan or irbesartan are being recalled. The new recall covers only about 1 percent of irbesartan drug products available in the United States, according to the FDA.

CNN Article
FDA Recall Alert

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »